{
  "docId": "019de076-8e54-70f4-b1ec-6643014b872e",
  "docSlug": "869b7bb859e037e0c2aa4b6e5865c5ed",
  "documentTitle": "AbCellera | Investor Conference Presentation Deck | 14 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 14,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a timeline-like bar to indicate the current development stage (IND-enabling) for two specific molecules.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-8e54-70f4-b1ec-6643014b872e/7",
  "deckHref": "/decks/019de076-8e54-70f4-b1ec-6643014b872e",
  "deckJsonHref": "/decks/019de076-8e54-70f4-b1ec-6643014b872e.json",
  "deckAnchorHref": "/decks/019de076-8e54-70f4-b1ec-6643014b872e#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.167,
        "w": 0.328,
        "x": 0.578,
        "y": 0.117
      },
      "kind": "paragraph",
      "text": "First two IND submissions anticipated in 2025. We intend to take additional first-in-class development candidates into IND-enabling studies in 2024 and 2025. $220M in non-dilutive funding from governments of Canada and British Columbia.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ef3338e-0560-4091-9415-4cf260a384fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.422,
        "w": 0.812,
        "x": 0.094,
        "y": 0.456
      },
      "kind": "table",
      "text": "Molecule, Target, Indication, Therapeutic Area, Potential Differentiation for ABCL575 and ABCL635",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e54ed59c-554b-4997-be8d-f03a765976d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.167,
        "w": 0.385,
        "x": 0.094,
        "y": 0.144
      },
      "kind": "title",
      "text": "Advancing an internal pipeline of potential first-in-class and best-in-class assets is a top priority to drive growth.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf95d165-cb7e-4f05-9bf9-0a2930093ef5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.022,
        "w": 0.105,
        "x": 0.094,
        "y": 0.044
      },
      "kind": "title",
      "text": "OUR PIPELINE",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "04be6ade-5c53-40af-bcfe-ca307179672e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}